Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2015 · 10-Q
Revenue—
Net Income$83.00K$83.00K+93.0% vs Q3 2014 EPS Diluted$0.00$0.00— vs Q3 2014 Operating Income$83,000+97.6% Operating Cash Flowderived$38,000−30.9%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Oct 29, 2015 · 29 d after period end